Selank: What a Small Human Comparison Can Show
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

Selank has been studied in people, but study design still matters. One 2008 report compared it with medazepam in patients with anxiety-related diagnoses. The report included sixty-two patients and described similar anxiety improvements between groups. An active-comparator result alone does not establish broad effectiveness or formal equivalence. The indexed abstract gives limited detail about methods and uncertainty. Larger, well-described trials and safety follow-up are needed to support stronger conclusions. FDA separately notes missing safety information and possible immune-reaction concerns for compounded Selank acetate. The clinical report should not be read as a guarantee of safety.

END CARD
Educational draft. Not medical advice. Sources and limitations accompany this film.

SOURCES
[1] Zozulia et al. (2008): Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in generalized anxiety disorders and neurasthenia
https://pubmed.ncbi.nlm.nih.gov/18454096/
Primary clinical report indexed as a randomized controlled trial; English abstract reviewed

[2] FDA: Certain bulk drug substances for use in compounding that may present significant safety risks
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
US regulator; Selank acetate entry in nominated-but-withdrawn table

EVIDENCE LIMITATIONS
Do not describe the trial as placebo-controlled or as establishing equivalence/noninferiority.
English abstract reviewed; full Russian-language trial methods were not independently audited.
Do not promise anxiety relief, absence of dependence or lack of adverse effects.
Do not assume a trial formulation is interchangeable with every product sold as Selank.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
Original topic requested by Nina; not attributed to an additional verified Facebook video.